Prograf: Essential Immunosuppression for Organ Transplant Rejection Prevention - Evidence-Based Review

Product Description: Prograf, known generically as tacrolimus, is an immunosuppressive macrolide lactone produced by Streptomyces tsukubaensis. It is a calcineurin inhibitor, fundamentally altering T-lymphocyte activation. Marketed in oral (capsules) and intravenous formulations, its primary and critical role is to prevent acute rejection in patients receiving allogeneic organ transplants, most commonly liver, kidney, and heart. It is a cornerstone of modern transplant medicine, enabling graft and patient survival through precise, lifelong modulation of the immune response.